Dr. Kahn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3181 SW Sam Jackson Park Rd
Portland, OR 97239Phone+1 503-494-1998
Education & Training
- Newton-Wellesley HospitalInternship, Transitional Year, 2014 - 2015
- The Warren Alpert Medical School of Brown UniversityClass of 2014
Certifications & Licensure
- OR State Medical License 2019 - 2025
- WA State Medical License 2022 - 2025
- ID State Medical License 2021 - 2023
- VA State Medical License 2015 - 2019
- MA State Medical License 2014 - 2015
- American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- 70 citationsRadiation therapy in management of sporadic and neurofibromatosis type 1-associated malignant peripheral nerve sheath tumorsJenna M. Kahn, Andy Gillespie, Maria Tsokos, John Ondos, Eva Dombi
Frontiers in Oncology. 2014-11-17 - 182 citationsThe brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor modelsStephen T. Durant, Li Zheng, Yingchun Wang, Kan Chen, Lingli Zhang
Science Advances. 2018-06-01 - 41 citationsOrally Bioavailable and Blood-Brain Barrier-Penetrating ATM Inhibitor (AZ32) Radiosensitizes Intracranial Gliomas in Mice.Jeremy Karlin, Jasmine Allen, Syed Farhan Ahmad, Gareth Hughes, Victoria Sheridan
Molecular Cancer Therapeutics. 2018-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: